Current BW Magazine Table of Contents

June 17, 2002 BW Magazine Table of Contents

June 17, 2002 The Stars of Europe Table of Contents
THE STARS
OF EUROPE

Introduction
Managers
Innovators
Agenda Setters
Financiers
Entrepreneurs
Challengers


JUNE 17, 2002

THE STARS OF EUROPE -- FINANCIERS
Back to Main Story

Christopher Evans
Chairman, Merlin Biosciences

 
Christopher Evans^Chairman, Merlin Biosciences^^^


  STORY TOOLS
Printer-Friendly Version
E-Mail This Story
Related Items Amelia Fawcett

Wojciech Kostrzewa

Kemal Dervis

Marc Breillout

John Duffield

Corrado Passera

Wolfgang van Betteray

Princess Gloria von Thurn und Taxis
A scientist turned entrepreneur, Christopher Evans is one of the forces behind Europe's emerging biotech industry. The 43-year-old Welshman has stakes in 20 European biotech companies and has funded a dozen others involved in cutting-edge areas such as stem cells and gene therapy. Despite volatile capital markets, he has managed to take four of them public. And as chairman of London-based venture-capital and advisory firm Merlin Biosciences, he aims to become one of the world's leading biotech investors.


In Europe, he is well on his way. Merlin invested $30 million in six companies last year, and participated in some of Europe's biggest biotech private-equity deals with investors like Nomura International and J.P. Morgan Chase. Altogether, Evans manages $365 million in three separate funds. One of his early investments was a company called Chiroscience that in 1999 merged with another, Celltech, to become Britain's biggest biotech company. It now has a market value of $2.5 billion. Not bad.

Evans' legendary Midas touch has earned him a knighthood in Britain and membership in Prime Minister Tony Blair's coterie of advisers. A tireless crusader for entrepreneurs, Evans advises Blair on ways to encourage innovative small businesses via tax and other incentives. Meanwhile, he maintains his ties with academic scientists as a professor of biotechnology at three British universities, including his alma mater, London's Imperial College of Science, Technology & Medicine. If Europe's biotech industry has a center, it's Chris Evans.



Get BusinessWeek directly on your desktop with our RSS feeds.XML

Add BusinessWeek news to your Web site with our headline feed.

Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video.

To subscribe online to BusinessWeek magazine, please click here.

Learn more, go to the BusinessWeekOnline home page
Back to Top
 
 
  MARKET INFO
DJIA 0 0.00
S&P 500 0 0.00
Nasdaq 0 0.00

Portfolio Service Update

Stock Lookup

Enter name or ticker



Copyright 2002, Bloomberg L.P.
Terms of Use | Privacy Policy